GHTM

Global Health and Tropical Medicine

  • GHTM
    • Vision
    • Mission
    • Governance
    • Scientific Advisory Board
  • News
    • Outreach
    • Events
      • GHTM Sessions
      • Workshops
    • Articles
    • Jobs
  • Research
    • Cross-cutting issues
      • Global Pathogen Dispersion and Population Mobility
      • Drug Discovery and Drug Resistance
      • Diagnostics
      • Public Health Information
      • Fair Research Partnerships
    • Research Groups
      • PPS – Population health, policies and services
      • THOP – TB, HIV and opportunistic diseases and pathogens
      • VBD – Vector borne diseases and pathogens
      • IHC – Individual health care
    • Research in numbers
      • 2020
      • 2019
      • 2018
      • 2017
    • Projects
      • Ongoing Projects
    • Members
      • Population health, policies and services
        • PPS PhD members
        • PPS non PhD members
      • TB, HIV and opportunistic diseases and pathogens
        • THOP PhD members
        • THOP non PhD members
      • Vector-borne diseases and pathogens
        • VBD PhD members
        • VBD non PhD members
      • Individual Health Care
        • IHC PhD members
        • IHC non PhD members
      • Technical / administrative support
  • Publications
  • Education
    • Master Theses
    • PhD Theses
  • Services
Home / Articles / New / Cascais Municipality SARS-CoV-2 sero-epidemiological survey: presentation of 1st phase results

Cascais Municipality SARS-CoV-2 sero-epidemiological survey: presentation of 1st phase results

15 Setembro, 2021

Cascais Municipality SARS-CoV-2 sero-epidemiological survey

 

Having as a mission «To foster research, training and implementation on Global Health and Tropical Medicine», GHTM R&D Centre’s researchers are very interested to better understand the percentage of SARS-CoV-2 infections in the Portuguese Speaking Communities, in Portugal or abroad.

In May 2020, the Cascais City Council established a partnership with GHTM to conduct a community-level seroprevalence survey, which included blood serology testing for SARS-CoV-2 antibodies together with socio-demographic and clinical questions.

The survey’s general goals were:

  • to estimate Cascais municipality SARS-Cov-2’s seroprevalence;
  • to identify associated socio-demographic and clinical factors .

This 1st phase of the study comprehended the pandemic period between May and September 2020, and had 12,032 respondents, corresponding to 5.62% of Cascais’ total population.

The lab assay used to detect SARS-Cov-2 IgG/IgM antibodies was the ROCHE SARS-CoV-2 Rapid Antibody Test.

The percentage of reactive tests was 1.3% (95% C.I.: 1.12 – 1.53) overall,  1.16 % among females and 1.56 % of males. The age group with the highest prevalence (2%) was 20-39 years old. Generally, there were not significant differences among educational levels or professional status. However, immigrant respondents had a significantly higher seroprevalence (2.99% vs 1.31%) p<0.05. Moreover, immigrants in the age group of 20-29 years old had significantly a higher seroprevalence when compared to the others (11.1%).

Furthermore, a significantly lower seroprevalence was found among patients reporting to have Diabetes (0,58%) and cardiovascular disease (0,76%), possibly reflecting higher levels of adherence to social distancing recommendations in these patients, for which a high risk for severe disease was reported since the beginning of the pandemic.

The sample comprised 1669 people who had done at least a PCR test, with 60 positives. Of these, unexpectedly, 32.8% did not test positive for IgG/IgM antibodies. Among the 5.3% of respondents who reported  contact with a suspected or infected person,  9.65% were reactive.

Of the 44.3% of respondents that mentioned having had one symptom congruent with COVID-19, 2.02% were serum-positive. 1.8% of these never did a PCR test and were seropositive. On the other hand, of the 158 serologic reactive, 31.6% were asymptomatic. The most frequent symptom of the disease was fatigue, referred by 37.4% of the reactive, although loss of taste or smell are the most specific COVID-19 symptoms, as 98.6% and 98.3%, respectively, of seronegative people did not show them.

These results highlight the largest serological SARS-Cov-2 survey in Portugal. Questionnaires are still being analysed and further results, corresponding to the time period between October 2020 and January 2021 will be reported soon.

 

GHTM’S RESEARCHERS INVOLVED IN THE ABOVE STUDY

Study Main Researchers: Ana, Sofia, Rosario

Ana Abecasis                          Sofia Seabra                           Rosário Martins

Other Study Researchers: Marta, Mafalda, Victor

Marta Pingarilho                       Mafalda Miranda                       Victor Pimentel

 

Share this:

  • Click to share on Facebook (Opens in new window)
  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Pinterest (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
  • Click to print (Opens in new window)

Trackbacks

  1. Session CCI6 » Serological survey of SARS-Cov2 in Cascais diz:
    2022-03-24 às 00:02

    […] Read the news article. […]

Events

PhD student from GHTM attended the India|EMBO Lecture Course

Ronise Silva, a PhD student under the Tropical Diseases and Global Health program at the Institute … [Read More...]

Registration for “Python applied to Biomedical Sciences” course is open!

GHTM informs that registration for the introduction course on Python programming language is … [Read More...]

BIOTROP, the biobank of GHTM-IHMT-NOVA, represented at the inauguration of the European headquarters of MIRRI-ERIC

  The Coordinator of the Biotropical Resources biobank (BIOTROP), Ana Paula Arez, and the … [Read More...]

Ciara O’Sullivan visited GHTM-IHMT and strengthened international relationship

  As part of the RESMALDETECT Exploratory Project, the GHTM-IHMT received a visit from Ciara … [Read More...]

Call for PhD Studentships

The Institute of Hygiene and Tropical Medicine (IHMT), Universidade Nova de Lisboa (NOVA), through … [Read More...]

IHMT | GHTM – APPLICATIONS ARE OPEN!

IHMT | GHTM - Applications are open for three research vacancies:   One position - PhD … [Read More...]

About GHTM

GHTM is a R&D Center that brings together researchers from IHMT with a track record in Tropical Medicine and International/Global Health. It aims at strengthening Portugal's role as a leading partner in the development and implementation of a global health research agenda. Our evidence-based interventions contribute to the promotion of equity in health and to improve the health of populations.

Contacts

Rua da Junqueira, 100
1349-008 Lisboa
Portugal
+351 213 652 600
+351 213 632 105

  • Facebook
  • YouTube

Subscribe Newsletter

  • How to get to GHTM/IHMT
  • GHTM Sessions
  • Research Groups
  • Cross-cutting issues
© Copyright 2023 IHMT-UNL Todos os Direitos Reservados.
  • Universidade Nova de Lisboa
  • Fundação para a Ciência e a Tecnologia

    Project UID/Multi/04413/2013

 

Loading Comments...